Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

NCT01569737 is registered in ClinicalTrials.gov with HRA Pharma as lead sponsor.

NCT NCT01569737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01569737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
Lead sponsor
HRA Pharma
Phase
Observational
Overall status
Completed
Start date
November 18, 2014
Completion date
June 29, 2018
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emergency contraception